PET scan in addition to conventional CT imaging
OtherPET scans, Pre and post radiation treatment
Other names: FDG PET
NCT Number: NCT00147472
The purpose of this trial is to determine the ability of positron emission tomography (PET) to detect residual cancer in neck lymph nodes of patients following curative treatment with radiation therapy for squamous cell cancer arising in the head and neck.
Patients with head and neck cancer (HNC) undergo treatment of curative intent; patients who are node positive (N2 N3 stages) undergo standard management which includes post-radiation planned neck dissection but two thirds of patients end up not having evidence of residual disease in neck dissection specimens; these patients could have avoided surgery. However, currently used standard tests, like computed tomography (CT) and/or magnetic resonance imaging (MRI) cannot reliably predict who is post-radiation disease free.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Juravinski Cancer Centre, Hamilton, Ontario, Canada
PET-Fluorodeoxyglucose scanning is an imaging test based on the increased uptake of radiolabelled glucose by tumour cells. PET might detect neck tumours better than other imaging tests. This is a cohort study in which patients with N2 N3 squamous cell carcinoma of the head and neck undergo a PET and a CT scan at baseline and then post-radiation therapy and chemotherapy. Then, they undergo neck dissection surgery. The PET and CT results are compared with the presence or absence of tumours in the neck nodes. If PET is sufficiently accurate in predicting the presence or absence of tumours in the neck nodes, then a neck dissection could be avoided.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All of the following criteria must be satisfied:
Exclusion criteria
PET scans, Pre and post radiation treatment
Other names: FDG PET
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Ontario Clinical Oncology Group (OCOG)
Other
A Prospective Cohort Study to Determine the Sensitivity of Positron Emission Tomography (PET) in Detecting Metastatic Cancer in Neck Lymph Nodes in Patients With Squamous Cell Head & Neck Cancer Managed With Primary Radiation Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06672471
Antibiotic Resistant Infection, Antibiotic Side Effect
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT03102229
Cancer of Esophagus, Cancer of Lung
The Bronx, New York, United States
View Trial DetailsNCT03853655
Buccal Mucosa Cancer, Cancer of Mouth
Guwahati, Assam, India
View Trial DetailsNCT05678348
Cancer of the Head and Neck, Carcinoma
St Louis, Missouri, United States
View Trial Details